Secondary Logo

Journal Logo

April 2013 - Volume 23 - Issue 4
pp: 181-249

Genetic variation-optimized treatment benefit of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: a 12-year follow-up study

Lee, Jen-Kuang; Wu, Cho-Kai; Tsai, Chia-Ti; More

Pharmacogenetics and Genomics. 23(4):181-189, April 2013.

The MAD1 1673 G→A polymorphism alters the function of the mitotic spindle assembly checkpoint and is associated with a worse response to induction chemotherapy and sensitivity to treatment in patients with advanced epithelial ovarian cancer

Santibáñez, Miguel; Gallardo, Dolores; Morales, Flavia; More

Pharmacogenetics and Genomics. 23(4):190-199, April 2013.

CYP2C9 promoter region single-nucleotide polymorphisms linked to the R150H polymorphism are functional suggesting their role in CYP2C9*8-mediated effects

Cavallari, Larisa H.; Vaynshteyn, David; Freeman, Kimberly M.; More

Pharmacogenetics and Genomics. 23(4):228-231, April 2013.

Nomenclature for alleles of the thiopurine methyltransferase gene

Appell, Malin L.; Berg, Jonathan; Duley, John; More

Pharmacogenetics and Genomics. 23(4):242-248, April 2013.